InvestorsObserver
×
News Home

How Will the Market React to Sio Gene Therapies Inc (SIOX) Stock Getting a Bearish Rating

Thursday, February 09, 2023 12:39 PM | InvestorsObserver Analysts

Mentioned in this article

How Will the Market React to Sio Gene Therapies Inc (SIOX) Stock Getting a Bearish Rating

The market has been down on Sio Gene Therapies Inc (SIOX) stock recently. SIOX gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bearish
Sio Gene Therapies Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on SIOX!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With SIOX Stock Today?

Sio Gene Therapies Inc (SIOX) stock is lower by -10.64% while the S&P 500 has risen 0.23% as of 12:31 PM on Thursday, Feb 9. SIOX has fallen -$0.05 from the previous closing price of $0.45 on volume of 4,519,570 shares. Over the past year the S&P 500 is down -8.72% while SIOX has fallen -46.75%. SIOX lost -$0.68 per share in the over the last 12 months. To screen for more stocks like Sio Gene Therapies Inc click here.

More About Sio Gene Therapies Inc

Sio Gene Therapies Inc is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The company is developing its pipeline for the treatment of debilitating diseases, including Parkinson's disease, GM1 gangliosidosis, and GM2 gangliosidosis. Click Here to get the full Stock Report for Sio Gene Therapies Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App